Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $304.50 | 1 | 49.1% |
| Food and Beverage | $216.10 | 6 | 34.8% |
| Education | $99.99 | 1 | 16.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $353.40 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $99.99 | 1 | $0 (2021) |
| Axonics, Inc. | $96.54 | 2 | $0 (2024) |
| C. R. Bard, Inc. & Subsidiaries | $50.23 | 1 | $0 (2023) |
| Rochester Medical Corporation | $20.43 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $449.94 | 5 | Boston Scientific Corporation ($353.40) |
| 2023 | $50.23 | 1 | C. R. Bard, Inc. & Subsidiaries ($50.23) |
| 2021 | $99.99 | 1 | Astellas Pharma US Inc ($99.99) |
| 2018 | $20.43 | 1 | Rochester Medical Corporation ($20.43) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $35.06 | General |
| Category: General - Kidney Stone Disease_URO | ||||||
| 07/02/2024 | Boston Scientific Corporation | Moses 550 DFL (Device) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Moses 550 DFL_URO | ||||||
| 07/01/2024 | Boston Scientific Corporation | Moses 550 DFL (Device) | Travel and Lodging | In-kind items and services | $304.50 | General |
| Category: Moses 550 DFL_URO | ||||||
| 02/28/2024 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $73.44 | General |
| Category: Urology | ||||||
| 01/27/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Urology | ||||||
| 02/03/2023 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $50.23 | General |
| Category: Urology | ||||||
| 09/09/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 12/21/2018 | Rochester Medical Corporation | MAGIC3 (Device) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 1,986 | 2,647 | $217,339 | $130,571 |
| 2022 | 26 | 2,055 | 2,741 | $233,209 | $140,749 |
| 2021 | 32 | 2,320 | 3,224 | $263,349 | $156,762 |
| 2020 | 33 | 2,378 | 3,220 | $287,247 | $172,848 |
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 307 | 386 | $43,183 | $26,466 | 61.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 19 | 153 | $32,808 | $20,404 | 62.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 87 | 98 | $30,505 | $19,355 | 63.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 152 | $23,950 | $15,016 | 62.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 176 | 199 | $14,309 | $7,910 | 55.3% |
| 52281 | Dilation of urethra using an endoscope | Office | 2023 | 20 | 27 | $10,805 | $7,673 | 71.0% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 21 | 21 | $7,276 | $4,107 | 56.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 167 | 227 | $5,301 | $4,068 | 76.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 49 | 49 | $7,087 | $3,583 | 50.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 33 | $6,508 | $3,359 | 51.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 207 | 290 | $2,946 | $2,404 | 81.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 21 | 21 | $4,045 | $2,388 | 59.0% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 11 | 18 | $10,346 | $2,002 | 19.4% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 43 | 59 | $1,523 | $1,492 | 98.0% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 127 | 175 | $1,891 | $1,371 | 72.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 22 | 22 | $2,271 | $1,159 | 51.0% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 27 | 29 | $2,238 | $1,069 | 47.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 21 | 42 | $1,991 | $1,055 | 53.0% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 20 | 20 | $1,396 | $1,006 | 72.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 11 | $1,176 | $827.98 | 70.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 63 | $1,336 | $738.71 | 55.3% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 44 | 60 | $704.40 | $500.28 | 71.0% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 44 | 60 | $676.48 | $467.28 | 69.1% |
| 87088 | Bacterial urine culture | Office | 2023 | 38 | 51 | $580.23 | $396.50 | 68.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 90 | 117 | $465.87 | $360.76 | 77.4% |
About Dr. Thomas Grimaldi, M.D
Dr. Thomas Grimaldi, M.D is a Urology healthcare provider based in Carmel, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487748802.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Grimaldi, M.D has received a total of $620.59 in payments from pharmaceutical and medical device companies, with $449.94 received in 2024. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Travel and Lodging" ($304.50).
As a Medicare-enrolled provider, Grimaldi has provided services to 8,739 Medicare beneficiaries, totaling 11,832 services with total Medicare billing of $600,929. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Carmel, NY
- Active Since 10/02/2006
- Last Updated 11/17/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1487748802
Products in Payments
- Moses 550 DFL (Device) $318.34
- Bulkamid (Device) $73.44
- Bard Urinary Drainage Bag (Device) $50.23
- Axonics (Device) $23.10
- MAGIC3 (Device) $20.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Carmel
Alexander Tatem, Md, MD
Urology — Payments: $344,345
Dr. Chad Reichard, Md, MD
Urology — Payments: $243,491
Dr. Jason Kovac, Md, MD
Urology — Payments: $147,555
Matthew Mellon, Md, MD
Urology — Payments: $129,392
Dr. Kenneth Ney, M.d, M.D
Urology — Payments: $63,942
Scott Farnham, Md, MD
Urology — Payments: $34,337